IA-2A positivity increases risk of progression within and across established stages of type 1 diabetes

dc.contributor.authorSims, Emily K.
dc.contributor.authorCuthbertson, David
dc.contributor.authorFerrat, Lauric A.
dc.contributor.authorBosi, Emanuele
dc.contributor.authorEvans‑Molina, Carmella
dc.contributor.authorDiMeglio, Linda A.
dc.contributor.authorNathan, Brandon M.
dc.contributor.authorIsmail, Heba M.
dc.contributor.authorJacobsen, Laura M.
dc.contributor.authorRedondo, Maria J.
dc.contributor.authorOram, Richard A.
dc.contributor.authorSosenko, Jay M.
dc.contributor.departmentPediatrics, School of Medicine
dc.date.accessioned2025-05-15T10:04:14Z
dc.date.available2025-05-15T10:04:14Z
dc.date.issued2025
dc.description.abstractAims/hypothesis: Accurate understanding of type 1 diabetes risk is critical for optimisation of counselling, monitoring and interventions, yet even within established staging classifications, individual time to clinical disease varies. Previous work has associated IA-2A positivity with increased type 1 diabetes progression but a comprehensive assessment of the impact of screening for IA-2A positivity across the natural history of autoantibody positivity has not been performed. We asked whether IA-2A would consistently be associated with higher risk of progression within and across established stages of type 1 diabetes in a large natural history study. Methods: Genetic, autoantibody and metabolic data from adult and paediatric autoantibody-negative (n=192) and autoantibody-positive (n=4577) relatives of individuals with type 1 diabetes followed longitudinally in the Type 1 Diabetes TrialNet Pathway to Prevention Study were analysed. Cox regression was used to compare cumulative incidences of clinical diabetes by autoantibody profiles and disease stages. Results: Compared with IA-2A- individuals, IA-2A+ individuals had higher genetic risk scores and clinical progression risk within single-autoantibody-positive (5.3-fold increased 5 year risk), stage 1 (2.2-fold increased 5 year risk) and stage 2 (1.3-fold increased 5 year risk) type 1 diabetes categories. Individuals with single-autoantibody positivity for IA-2A showed increased metabolic dysfunction and diabetes progression compared with people who were autoantibody negative, those positive for another single autoantibody, and IA-2A- stage 1 individuals. Individuals at highest risk within the single-IA-2A+ category included children (HR 14.2 [95% CI 1.9, 103.1], p=0.009), individuals with IA-2A titres above the median (HR 3.5 [95% CI 1.9, 6.6], p<0.001), individuals with high genetic risk scores (HR 1.4 [95% CI 1.2,1.6], p<0.001) and individuals with HLA DR4-positive status (HR 3.7 [95% CI 1.6, 8.3], p=0.002). When considering all autoantibody-positive individuals, progression risk was similar for euglycaemic IA-2A+ individuals and dysglycaemic IA-2A- individuals. Conclusions/interpretation: IA-2A positivity is consistently associated with increased progression risk throughout the natural history of type 1 diabetes development. Individuals with single-autoantibody positivity for IA-2A have a greater risk of disease progression than those who meet stage 1 criteria but who are IA-2A-. Approaches to incorporate IA-2A+ status into monitoring strategies for autoantibody-positive individuals should be considered.
dc.eprint.versionFinal published version
dc.identifier.citationSims EK, Cuthbertson D, Ferrat LA, et al. IA-2A positivity increases risk of progression within and across established stages of type 1 diabetes. Diabetologia. 2025;68(5):993-1004. doi:10.1007/s00125-025-06382-x
dc.identifier.urihttps://hdl.handle.net/1805/48146
dc.language.isoen_US
dc.publisherSpringer
dc.relation.isversionof10.1007/s00125-025-06382-x
dc.relation.journalDiabetologia
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourcePMC
dc.subjectAutoantibodies
dc.subjectIA-2A
dc.subjectIslet antigen-2
dc.subjectPrecision medicine
dc.subjectPrediction
dc.subjectProgression
dc.subjectStratification
dc.subjectType 1 diabetes
dc.titleIA-2A positivity increases risk of progression within and across established stages of type 1 diabetes
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Sims2025Positivity-CCBYNCND.pdf
Size:
1.54 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: